Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice
Open Access
- 19 May 2008
- journal article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 6 (1), 26
- https://doi.org/10.1186/1479-5876-6-26
Abstract
Interleukin-12 (IL-12) is a cytokine well known for its role in immunity. A lesser known function of IL-12 is its role in hematopoiesis. The promising data obtained in the preclinical models of antitumor immunotherapy raised hope that IL-12 could be a powerful therapeutic agent against cancer. However, excessive clinical toxicity, largely due to repeat dose regimens, and modest clinical response observed in the clinical trials have pointed to the necessity to design protocols that minimize toxicity without affecting the anti-tumor effect of IL-12. We have focused on the lesser known role of IL-12 in hematopoiesis and hypothesized that an important clinical role for IL-12 in cancer may be as an adjuvant hematological cancer therapy. In this putative clinical function, IL-12 is utilized for the prevention of cancer therapy-related cytopenias, while providing concomitant anti-tumor responses over and above responses observed with the primary therapy alone. This putative clinical function of IL-12 focuses on the dual role of IL-12 in hematopoiesis and immunity.Keywords
This publication has 76 references indexed in Scilit:
- Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcomaBlood, 2007
- Prevention of Ultraviolet Radiation–Induced Immunosuppression by (−)-Epigallocatechin-3-Gallate in Mice Is Mediated through Interleukin 12–Dependent DNA RepairClinical Cancer Research, 2006
- Thrombopoietic Factors in Chronic Bone Marrow Failure States: The Platelet Problem RevisitedClinical Cancer Research, 2005
- New TPO treatment schedules of increased safety and efficacy: pre‐clinical validation of a thrombopoiesis simulation modelBritish Journal of Haematology, 2003
- Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialThe Lancet, 2003
- Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repairNature, 2001
- Targeted Approaches for the Treatment of ThrombocytopeniaThe Oncologist, 2001
- Interleukin 1 Trials in Cancer Patients: A Review of the Toxicity, Antitumor and Hematopoietic EffectsThe International Journal of Cell Cloning, 1996
- Interleukin-1 in the treatment of cancerPharmacology & Therapeutics, 1995
- High-Dose Chemotherapy of Metastatic Breast Cancer: A ReviewCancer Investigation, 1995